FindTrial
Sign In

Study for the correlation between serine protease inhibitor B1 with diabetic nephropathy of type 2 diabetes mellitus

Study for the correlation between serine protease inhibitor B1 with diabetic nephropathy of type 2 diabetes mellitus

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1900020850
Enrollment
Unknown
Registered
2019-01-21
Start date
2019-01-20
Completion date
Unknown
Last updated
2019-01-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

type 2 diabetes mellitus

Interventions

Case series:none

Sponsors

Cheng Xingbo
Lead Sponsor

Eligibility

Sex/Gender
All
Age
20 Years to 80 Years

Inclusion criteria

Inclusion criteria: patients with type 2 diabetes mellitus or healthy people

Exclusion criteria

Exclusion criteria: patients with age less than 20 years old; cardiac function (NYHA classification) > grade II; cirrhosis; chronic lung disease; cerebral infarction; other kidney diseases; with diabetic ketoacidosis or other acute complications; in pregnancy or lactation.

Design outcomes

Primary

MeasureTime frame
serine protease inhibitor B1;—

Countries

China

Contacts

Public ContactCheng Xingbo

the First Affiliated Hospital of Soochow University

xingbo1107@sohu.com+86 13862043880

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026